Harlow, UK, 25 February 2015
Diamond BioPharm Ltd. announces today the incorporation of its US subsidiary, Diamond Pharma Services, Inc.
Clients of Diamond Pharma Services, Inc. will have access to product development and regulatory affairs expertise for the American market. Based out of Boston, Massachusetts, the new US team will be comprised of staff with a proven record in supporting biotechnology and pharmaceutical companies at the frontiers of therapeutic research and development, offering both strategic and operational expertise in line with FDA requirements.
In Europe, Diamond has provided support to companies developing products in the area of new chemical-entities, biologics and advanced therapies, including gene and cell therapies. Notable successes include assisting in the successful market approval of the first gene therapy in Europe.
“We are excited to realise a long time ambition to expand our services into the USA,” said Dr Maureen Graham, Managing Director of Diamond BioPharm Ltd. “The new US company will allow us to continue to deliver an outstanding consulting service to our clients through all stages of product development, and to provide support and leadership during interactions with regulatory agencies in a harmonised global approach for the US and Europe, utilising an in-house team of experts.”
As part of the expansion, Sean Russell will take on the role of Managing Director for Diamond Pharma Services, Inc. with responsibility for growing the US team and ensuring the delivery of US regulatory affairs and product development expertise.
About Diamond BioPharm Ltd.
Diamond BioPharm Ltd. was founded in 2005 by Dr Maureen Graham. The company is part of the Diamond Pharma Services group of companies, a leading technical and scientific consulting group serving the biotechnology and pharmaceutical industry, with an emphasis on:
- Regulatory Affairs: from product concept to registration and beyond
- Product Development: Chemistry manufacturing and control (CMC), non-clinical and clinical
- Pharmacovigilance: Clinical trial (phase I-IV), post marketing and QPPV services
- Compliance: GLP, GMP, GCP and QP services
About Diamond Pharma Services, Inc.
Diamond Pharma Services, Inc. was founded in February 2015 as a subsidiary of Diamond BioPharm Ltd., with offices in Boston, Massachusetts and responsible for delivering US expertise in regulatory affairs and product development to new and existing clients.
For more information, please visit the Diamond Pharma Services website www.diamondpharmaservices.com or contact us on +44 845 070 4336 or +1 617 535 7621